September 30, 2008

Dr. Karin Aßmann
Phone 	+49 69 218-2230
Fax 	+49 69 218-62230
karin.assmann@evonik.com
Evonik Degussa GmbH
Weissfrauenstrasse 9
60287 Frankfurt am Main
Phone 	+49 69 218-01
Fax 	+49 69 218-3118
www.evonik.com

Chairman of the Supervisory Board
Dr. Werner Müller
Management Board
Dr. Klaus Engel (Chairman), 
Dr. Alfred Oberholz (dep.chm.),
Ralf Blauth, Heinz-Joachim Wagner, 
Patrik Wohlhauser

Registered office: Essen
Local Court: Essen
Commercial Register B 20227
Homogeneous Catalysis: Evonik has Granted Exclusive License to Solvias 

Evonik Degussa GmbH, Essen (Germany), has granted an exclusive license to Solvias AG, Basel (Switzerland), to develop, manufacture, and market the catASium® and cataCXium® ligand product lines. Evonik, a leading supplier of catalytic system solutions, remains active in homogenous catalysis as manufacturer and vendor of catMETium® catalysts for metathesis reactions. Solvias is one of the most capable excellence centers for homogeneous catalysis and High Throughput Screening (HTS). 

“We developed catASium® and cataCXium® in record time and successfully introduced it to the market,” said Dr. Jürgen Krauter, the head of marketing in the Catalysts Business Line of Evonik. “We are pleased to pass on these activities to a highly competent partner such as Solvias, who will further advance these technologies.” 

catASium® is a product line of chiral ligands for asymmetric hydrogenations that consists of highly variable chiral ligands and their associated Rh complexes. cataCXium® is a line of CX coupling ligands with proven success in solving industrial CX coupling problems. 

Company information
Evonik Industries is the creative industrial group from Germany which operates in three business areas: Chemicals, Energy and Real Estate. Evonik is a global leader in specialty chemicals, an expert in power generation from hard coal and renewable energies, and one of the largest private residential real estate companies in Germany. Our strengths are creativity, specialization, continuous self-renewal, and reliability. Evonik is active in over 100 countries around the world. In its fiscal year 2007 about 43,000 employees generated sales of about €14.4 billion and an operating profit (EBITDA) of more than €2.2 billion. 

Disclaimer
In so far as forecasts or expectations are expressed in this press release or where our statements concern the future, these forecasts, expectations or statements may involve known or unknown risks and uncertainties. Actual results or developments may vary, depending on changes in the operating environment. Neither Evonik Industries AG nor its group companies assume an obligation to update the forecasts, expectations or statements contained in this release.